Contents

Search

Chlamydia trachomatis + Neisseria gonorrhoeae DNA (GenProbe, Amplicor)

Principle: - molecular diagnostic test for - Chlamydia trachomatis - Neisseria gonorrhoeae Method: - polymerase chain reaction (PCR) - detection with DNA probe Specimen: - urethral swab - urine is adequate specimen [4] - self-collected vulvovaginal swabs at least as accurate as clinician-collected endocervical swabs [3]

Related

Chlamydia trachomatis Neisseria gonorrhoeae (gonococcus, GC)

Specific

Chlamydia trachomatis DNA Neisseria gonorrhoeae DNA

General

infectious agent nucleic acid

References

  1. Kwan B et al. Sensitivity of 20-minute voiding intervals in men testing for Chlamydia trachomatis. Sex Transm Dis 2012 May; 39:405. PMID: 22504609
  2. Journal Watch 25(1):10, 2005 Centers for Disease Control and Prevention (CDC). Chlamydia screening among sexually active young female enrollees of health plans--United States, 1999-2001. MMWR Morb Mortal Wkly Rep. 2004 Oct 29;53(42):983-5. PMID: 15514579 http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5342a1.htm
  3. Stewart CMW Assessment of self taken swabs versus clinician taken swab cultures for diagnosing gonorrhoea in women: single centre, diagnostic accuracy study. BMJ 2012;345:e8107 PMID: 23236033 http://www.bmj.com/content/345/bmj.e8107 - Schoeman SA et al Assessment of best single sample for finding chlamydia in women with and without symptoms: a diagnostic test study. BMJ 2012;345:e8013 PMID: 23236032 http://www.bmj.com/content/345/bmj.e8013
  4. Journal Watch 25(1):10, 2005 Centers for Disease Control and Prevention (CDC). Chlamydia screening among sexually active young female enrollees of health plans--United States, 1999-2001. MMWR Morb Mortal Wkly Rep. 2004 Oct 29;53(42):983-5. PMID: 15514579 http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5342a1.htm
  5. FDA News Release. May 23, 2019 FDA clears first diagnostic tests for extragenital testing for chlamydia and gonorrhea. FDA clears first diagnostic tests for extragenital testing for chlamydia and gonorrhea. https://www.fda.gov/news-events/press-announcements/fda-clears-first-diagnostic-tests-extragenital-testing-chlamydia-and-gonorrhea